Trevi Therapeutics Aktie
10,40
USD
-0,54
USD
-4,94
%
10,20
USD
-0,20
USD
-1,92
%
Werbung
Trevi Therapeutics Aktie Analyse
| 03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
| 03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung